These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 669802)
1. Inverse relationship between the susceptibility of lipopolysaccharide (lipid A)-pretreated mice to the hypothermic and lethal effect of lipopolysaccharide. Greer GG; Rietschel ET Infect Immun; 1978 May; 20(2):366-74. PubMed ID: 669802 [TBL] [Abstract][Full Text] [Related]
2. Lipid A-induced tolerance and hyperreactivity to hypothermia in mice. Greer GG; Rietschel ET Infect Immun; 1978 Feb; 19(2):357-68. PubMed ID: 631875 [TBL] [Abstract][Full Text] [Related]
3. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms. Matsuura M; Kiso M; Hasegawa A; Nakano M Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521 [TBL] [Abstract][Full Text] [Related]
4. Interferon and cytotoxic factor (cytotoxin) released in the blood of mice infected with Mycobacterium bovis BCG. II. Influence of time after BCG inoculation on production of interferon and cytotoxin by capsular polysaccharide of Klebsiella pneumoniae or by bacterial lipopolysaccharide and on hyperreactivity to their lethal effects. Kato N; Nakashima I; Ohta M; Naito S Microbiol Immunol; 1979; 23(5):395-402. PubMed ID: 388156 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Astiz ME; Saha DC; Brooks K; Carpati CM; Rackow EC Circ Shock; 1993 Mar; 39(3):194-8. PubMed ID: 8453743 [TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Zuckerman SH; Qureshi N Infect Immun; 1992 Jul; 60(7):2581-7. PubMed ID: 1612727 [TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses. Deiters U; Gumenscheimer M; Galanos C; Mühlradt PF Infect Immun; 2003 Aug; 71(8):4456-62. PubMed ID: 12874325 [TBL] [Abstract][Full Text] [Related]
8. Induction of lethal shock and tolerance by Porphyromonas gingivalis lipopolysaccharide in D-galactosamine-sensitized C3H/HeJ mice. Tanamoto K Infect Immun; 1999 Jul; 67(7):3399-402. PubMed ID: 10377118 [TBL] [Abstract][Full Text] [Related]
9. Lethal effect and apoptotic DNA fragmentation in response of D-GalN-treated mice to bacterial LPS can be suppressed by pre-exposure to minute amount of bacterial LPS: dual role of TNF receptor 1. Zhou BR; Gumenscheimer M; Freudenberg MA; Galanos C World J Gastroenterol; 2005 Jun; 11(22):3398-404. PubMed ID: 15948245 [TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Freudenberg MA; Galanos C Infect Immun; 1988 May; 56(5):1352-7. PubMed ID: 3356468 [TBL] [Abstract][Full Text] [Related]
11. Hepatic drug-metabolizing enzyme system and endotoxin tolerance: structural requirement of LPS in induction of an early tolerance. Egawa K; Yoshida M; Sakaino R; Kasai N Microbiol Immunol; 1984; 28(11):1181-90. PubMed ID: 6521669 [TBL] [Abstract][Full Text] [Related]
12. Experimental salmonellosis: hypersensitivity to cell wall lipopolysaccharide and anti-infectious resistance of mice infected with Salmonella. Kawakami M; Hara Y; Osawa N Infect Immun; 1971 Nov; 4(5):519-24. PubMed ID: 4117290 [TBL] [Abstract][Full Text] [Related]
13. Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria. Bradley SG; Munson AE; Dewey WL; Harris LS Infect Immun; 1977 Aug; 17(2):325-9. PubMed ID: 330405 [TBL] [Abstract][Full Text] [Related]
14. Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. Cornelissen JJ; Mäkel I; Algra A; Benaissa-Trouw BJ; Schellekens JF; Kraaijeveld CA; Verhoef J J Infect Dis; 1993 Apr; 167(4):876-81. PubMed ID: 8450253 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies. Ward DC; Michalek SM; McGhee JR Clin Exp Immunol; 1988 Apr; 72(1):157-63. PubMed ID: 3293850 [TBL] [Abstract][Full Text] [Related]
16. Does the formation of lipopolysaccharide tolerance require intact vagal innervation of the liver? Ivanov AI; Kulchitsky VA; Sugimoto N; Simons CT; Romanovsky AA Auton Neurosci; 2000 Dec; 85(1-3):111-8. PubMed ID: 11189017 [TBL] [Abstract][Full Text] [Related]
17. Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A. Dijkstra J; Mellors JW; Ryan JL Infect Immun; 1989 Nov; 57(11):3357-63. PubMed ID: 2807528 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Takada H; Galanos C Infect Immun; 1987 Feb; 55(2):409-13. PubMed ID: 3804443 [TBL] [Abstract][Full Text] [Related]